Effectiveness of enhanced external counter pulsation on clinical profile and health-related quality of life in patients with coronary heart disease: a systematic review was just recently published in Via Medical. The authors Vikram Singh, Girija Kumari1, 3, Bimal Chhajer2, Ashok Kumar Jhingan3, and Saurabh Dahiya state in the beginning of the article “Enhanced External Counter Pulsation (EECP) is a non-invasive United States Food and Drug Administration (FDA) approved outpatient treatment option for the complex problem of angina, a common symptom of coronary heart disease. A systematic review of the literature searched to assess the effect of EECP on the clinical profile that comprised physiological measurements, biochemical assessments, cardiac clinical symptoms, physical functional status, and Health-Related Quality of Life (HRQoL) in Coronary Heart Disease (CHD) patients.”
Recent News
Recently Published Case Study Explores the Possibility of Using EECP Therapy to Treat Long – COVID POTS
Russian Publications on EECP Therapy Now Added to IEECPS Bibliography
Short-term External Counterpulsation Augments Cerebral Blood Flow and Tissue Oxygenation in Chronic Cerebrovascular Occlusive Disease Presented at ESC
EECP Presentation at ACIM in November
New Counterpulsation Center Opens at Xiangtan City Hospital in China
Russian Publications on EECP Therapy Now Added to IEECPS Bibliography
Short-term External Counterpulsation Augments Cerebral Blood Flow and Tissue Oxygenation in Chronic Cerebrovascular Occlusive Disease Presented at ESC
EECP Presentation at ACIM in November
New Counterpulsation Center Opens at Xiangtan City Hospital in China
Join the IEECPS!
The IEECPS gives you the opportunity to make a contribution and be part of a world wide effort to improve the utilization of EECP Therapy to slow down or prevent the progression of cardiovascular disease.